Cardio Diagnostics Holdings, Inc. Stock Issued During Period, Shares, Purchase of Assets
Cardio Diagnostics Holdings, Inc. (CDIO) reported Stock Issued During Period, Shares, Purchase of Assets of 6.47 million shares for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets · last filed 2022-11-07
- 2022-09-30: Stock Issued During Period, Shares, Purchase of Assets 9 month 6.47M shares.
| Period end | Stock Issued During Period, Shares, Purchase of Assets 9 month |
|---|---|
| 2022-09-30 | 6.47M shares 10-Q · filed 2022-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |